- Home
- IDAI vs IOBT Comparison
IDAI vs IOBT Comparison
Compare IDAI & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IDAI | IOBT |
|---|---|---|
| Founded | 2016 | 2014 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9M | 12.7M |
| IPO Year | 2022 | 2021 |
Fundamental Metrics
Financial Performance| Metric | IDAI | IOBT |
|---|---|---|
| Price | $2.45 | $0.04 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 4 |
| Target Price | ★ $12.00 | $2.25 |
| AVG Volume (30 Days) | 32.1K | ★ 40.5M |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 76.50 | 26.77 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $103.06 | N/A |
| Revenue Next Year | $140.06 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.80 | $0.03 |
| 52 Week High | $5.28 | $2.79 |
Technical Indicators
Market Signals| Indicator | IDAI | IOBT |
|---|---|---|
| Relative Strength Index (RSI) | 45.04 | 25.94 |
| Support Level | $2.31 | N/A |
| Resistance Level | $2.80 | $0.22 |
| Average True Range (ATR) | 0.17 | 0.02 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 24.39 | 15.92 |
Price Performance
Historical ComparisonAbout IDAI T Stamp Inc.
T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility. The artificial intelligence-powered solutions segment generates revenue principally from software licenses, professional services, and recurring Software-as-a-Service ("SaaS") revenue.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.